New transplant method aims to stop deadly complication, reduce need for lifelong drugs
NCT ID NCT05236764
Summary
This study is testing a modified stem cell transplant for adults and children with serious blood cancers or disorders. The goal is to treat the disease while reducing the risk of a dangerous complication called graft-versus-host disease (GvHD). Researchers are using a special machine to filter certain cells from a half-matched family donor's blood before the transplant, hoping this allows patients to stop taking strong anti-rejection drugs sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.